Guava leaves, a potent natural remedy, offer remarkable health benefits when consumed on an empty stomach. They aid in weight ...

For centuries, milk and ghee have been vital to Indian nutrition and Ayurveda, offering restorative qualities. Combined, they ...

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare ...

A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's ...

Professor Guan Xinyuan (left) and his research team developed the 'Cancer Immunology Data Engine', which is publicly ...

Pune (Maharashtra) [India], October 27: Pune-based power electronics company introduces a 100% indigenously designed & built AC-DC converter product to power EV fast chargers. These will be marketed ...

At SEMERGEN 2025, experts explain how dermocosmetics bridging dermatology and cosmetics can help GPs manage skin concerns, ...

Immunology's transformative impact on global health, from Nobel Prizes to COVID-19 vaccines, underscores its critical role in ...

Omeros stock jumps 164% as Novo Nordisk acquires global rights to zaltenibart, with potential milestones reaching $2.1 ...